Covid-19
Brazil turns down request to vaccinate children, adolescents with COVID vaccines
Brazilian Health Regulatory Agency, Anvisa, said it turned down a request by the Brazilian Butantan Institute for approval of Chinese CoronaVac to vaccinate children aged between 3 and 17.
Anvisa stated this on Wednesday that the request was not approved due to lack of sufficient data.
The Instituto Butantan biologic research centre is producing CoronaVac.
“Vaccination of children and teenagers with CoronaVac vaccine is not approved. It was impossible to prove the vaccine’s efficacy and safety for this age group, based on information by the Butantan Institute.
READ ALSO: Actress drops bombshell, advises people not to take COVID vaccines
“Data on immunogenicity leave unclear the duration of protection provided by the immunizing agent,” said Anvisa.
The agency also noted that there was no conclusion on side effects or vaccine efficacy among children with associated diseases, chiefly due to the insufficient number of tests’ participants.
Only the Pfizer/BioNTech vaccine has so far been approved by Anvisa for vaccinating people over 12 years old in Brazil.
However, the Janssen laboratory has received a permit to conduct experiments with children under 18 in the Latin American country
-
Football1 week agoFULL LIST: Eight stadiums to host 2027 Women’s World Cup in Brazil
-
Comments and Issues1 week agoWavy fuel prices and deepening cost-of-living crises in Nigeria
-
Business7 days agoDangote Refinery IPO: Can small investors really make money from the shares?
-
Business3 days agoCBN reduces MPR by 350bps to 23% in major monetary policy shift
-
Business5 days agoJetour takes T1 adventure SUV experience to Abuja, targets growing Nigerian market
-
Football5 days agoNigeria vs Colombia: Falconets battle for U-20 World Cup semi-final ticket
-
Football6 days agoBreaking:Brighton shocks Arsenal 3-0 as Gunners’ perfect start comes crashing down
-
Business5 days agoNMDPRA moves against petrol price gouging as pump prices rise to N1,450